2252
S. SOBHANI ET AL.
4,4’-[(4-Nitrophenyl)methylene]
bis(3-methyl-1-phenyl-pyrazol-5-ol)
(3d). 1H NMR (DMSO-d6, 500 MHz): d 2.35 (s, 6 H), 5.13 (s, 1 H), 7.25–7.27 (m,
2 H), 7.44 (t, 4 H, J ¼ 7.0 Hz), 7.52 (d, 2 H, J ¼ 8.1 Hz), 7.71 (d, 4 H, J ¼ 7.6 Hz),
8.17 (d, 2 H, J ¼ 8.2 Hz), 13.86 (brs, 2 H) ppm; 13C NMR (DMSO-d6, 125 MHz):
d 34.1, 56.9, 121.5, 124.2, 126.6, 129.5, 129.8, 146.8, 147.2, 151.2 ppm; IR (KBr): t
3056 (O–H) cmꢁ1; mp 229–231 ꢀC; MS: m=z (%) ¼ 307 (9.2), 174 (18.3).
4,4’-[(4-Chlorophenyl)methylene] bis(3-methyl-1-phenyl-pyrazol-5-ol)
(3e). 1H NMR (DMSO-d6, 500 MHz): d 2.32 (s, 6 H), 4.97 (s, 1 H), 7.26 (d, 4 H,
J ¼ 8.2 Hz), 7.34 (d, 2 H, J ¼ 8.0 Hz), 7.44 (t, 4 H, J ¼ 7.1 Hz), 7.71 (d, 4 H,
J ¼ 7.6 Hz), 12.40 (brs, 1 H), 13.87 (brs, 1 H) ppm; 13C NMR (DMSO-d6,
125 MHz): d 33.4, 40.1, 121.4, 126.4, 128.9, 129.8, 130.0, 131.4, 142.0, 147.1 ppm;
IR (KBr): t 3044 (OꢁH) cmꢁ1; mp 212–214 ꢀC; MS: m=z (%) ¼ 296 (6.3), 174 (14.0).
4,4’-[(2-Chlorophenyl)methylene] bis(3-methyl-1-phenyl-pyrazol-5-ol)
(3f). 1H NMR (DMSO-d6, 400 MHz): d 2.29 (s, 6 H), 5.14 (s, 1 H), 7.22–7.33 (m,
4 H), 7.40 (d, 1 H, J ¼ 7.8 Hz), 7.44 (t, 4 H, J ¼ 7.6 Hz), 7.70 (d, 4 H, J ¼ 7.6 Hz),
7.80 (d, 1 H, J ¼ 7.1 Hz), 13.92 (brs, 2 H) ppm; 13C NMR (DMSO-d6, 100 MHz):
d 32.4, 120.7, 123.6, 126.9, 128.0, 128.9, 129.4, 130.3, 135.9, 137.4, 140.6,
141.2 ppm; IR (KBr): t 3450 (OꢁH) cmꢁ1; mp 235–237 ꢀC; MS: m=z (%) ¼ 296
(6.6), 185 (12.2).
4,4’-[(3-Methyl)methylene] bis(3-methyl-1-phenyl-pyrazol-5-ol) (3g).
1H NMR (DMSO-d6, 400 MHz): d 2.25 (s, 3 H), 2.31 (s, 6 H), 4.91 (s, 1 H), 6.98
(d, 1 H, J ¼ 7.6 Hz), 7.06 (s, 1 H), 7.07 (d, 1 H, J ¼ 6.8 Hz), 7.16 (t, 1 H, J ¼ 7.2 Hz),
), 7.25 (t, 2 H, J ¼ 7.2 Hz), 7.44 (t, 4 H, J ¼ 7.6 Hz), 7.71 (d, 4 H, J ¼ 7.6 Hz), 13.98
(brs, 2 H) ppm; 13C NMR (DMSO-d6, 100 MHz): d 12.1, 21.7, 33.6, 121.0, 124.8,
126.0, 127.1, 128.2, 128.5, 129.4, 137.5, 142.7, 146.7 ppm; IR (KBr): t 3023 (OꢁH)
cmꢁ1; mp 193–194 ꢀC; MS: m=z (%) ¼ 276 (28.4), 174 (21.0).
4,4’-[(4-Methoxy)methylene] bis(3-methyl-1-phenyl-pyrazol-5-ol) (3h).
1H NMR (DMSO-d6, 250 MHz): d 2.12 (s, 6 H), 3.72 (s, 3 H), 4.73 (s, 1 H), 6.77
(d, 2 H, J ¼ 8.7 Hz), 7.08–7.12 (m, 4 H), 7.21–7.28 (m, 4 H), 7.54 (d, 4 H, J ¼ 7.9 Hz)
) ppm; 13C NMR (DMSO-d6, 63 MHz): d 11.6, 32.4, 54.9, 105.0, 113.5, 120.4, 125.4,
128.1, 128.9, 129.2, 134.6, 137.9, 146.1, 157.5 ppm; IR (KBr): t 3060 (OꢁH) cmꢁ1
;
mp 176–177 ꢀC; MS: m=z (%) ¼ 466 (0.2, [Mþ]), 292 (100), 174 (32).
4,4’-[(4-Hydroxyphenyl)methylene]bis(3-methyl-1-phenyl-pyrazol-5-ol)
(3i). 1H NMR (DMSO-d6, 500 MHz): d 2.31 (s, 6 H), 4.86 (s, 1 H), 6.67 (d, 2 H,
J ¼ 8.0), 7.06 (d, 2 H, J ¼ 8.5 Hz), 7.24 (t, 2 H, J ¼ 7.0 Hz), 7.44 (t, 4 H, J ¼ 8.0 Hz),
), 7.72 (d, 4 H, J ¼ 8.0 Hz), 9.16 (brs, 1 H, OH), 12.40 (brs, 1 H, OH), 13.95 (brs, 1 H,
OH) ppm ; 13C NMR (DMSO-d6, 125 MHz): d 12.5, 33.2, 115.7, 121.4, 126.4, 128.9,
129.8, 133.2, 143.6, 147.0, 156.4 ppm; IR (KBr): t 3420 (OꢁH) cmꢁ1; mp
150–151 ꢀC; MS: m=z (%) ¼ 296 (30.2), 174 (91.4).
4,4’-[(2-Hydroxyphenyl)methylene]bis(3-methyl-1-phenyl-pyrazol-5-ol)
(3j). 1H NMR (DMSO-d6, 250 MHz): d 2.28 (s, 6 H), 5.16 (s, 1 H), 6.66–6.75 (m, 2
H), 6.97 (t, 1 H, J ¼ 7.7 Hz), 7.22 (t, 2 H, J ¼ 7.2 Hz), 7.42 (t, 4 H, J ¼ 7.7 Hz), 7.55
(d, 1 H, J ¼ 7.2 Hz), 7.69 (d, 4 H, J ¼ 8.1 Hz) ppm; 13C NMR (DMSO-d6, 63 MHz): d
11.8, 27.3, 104.5, 114.9, 118.6, 120.6, 125.5, 126.9, 128.8, 128.9, 129.3, 137.5, 146.3,